- Latest week
- 10 Jul 2026
- Close
- 2.030000
- Fair value
- 2.100812
- Next-week expectancy
- Undecided 47.45%
PTPN Chart Pack
Pentixapharm Holding AG
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, PTPN fell 1.46%, moving from 2.06 to 2.03. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -12.70 and has softened across the 12-week window. Market Dynamics is 0.62 on the latest week. Next-week expectancy is undecided at 47.45% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.03
- 12-Week Change
- -1.46%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 47.45%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -12.70
- Market Dynamics
- 0.62
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.03
- 12-Week Change
- -1.46%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 47.45%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -12.70
- Market Dynamics
- 0.62
Over the latest 12 completed weeks ending 2026-07-10, PTPN fell 1.46%, moving from 2.06 to 2.03. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -12.70 and has softened across the 12-week window. Market Dynamics is 0.62 on the latest week. Next-week expectancy is undecided at 47.45% based on similar historical setup states.
Industry Peers
Austria equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| VVYN Vivoryon Therapeutics N.V. | VIE | 10 Jul 2026 | 1.11 | 1.50 | 1.10 | 1.38 | 24.43% |
| HPHA Heidelberg Pharma AG | VIE | 10 Jul 2026 | 2.59 | 2.74 | 2.59 | 2.66 | 2.70% |
| REGN Regeneron Pharmaceuticals, Inc. | VIE | 10 Jul 2026 | 575.80 | 593.70 | 560.00 | 578.90 | 0.54% |
| GMAB Genmab A/S | VIE | 10 Jul 2026 | 250.00 | 257.70 | 245.00 | 250.30 | 0.12% |
| PHM Pharma Mar, S.A. | VIE | 10 Jul 2026 | 79.48 | 83.04 | 78.99 | 79.40 | -0.10% |
| ALKB ALK-Abelló A/S | VIE | 10 Jul 2026 | 32.66 | 32.76 | 32.12 | 32.48 | -0.55% |
| BMRN BioMarin Pharmaceutical Inc. | VIE | 10 Jul 2026 | 52.12 | 53.02 | 51.06 | 51.72 | -0.77% |
| TUBI Financière de Tubize SA | VIE | 10 Jul 2026 | 222.00 | 222.00 | 214.60 | 218.80 | -1.44% |
| LKFT Lakefront Biotherapeutics NV | VIE | 10 Jul 2026 | 26.86 | 26.88 | 26.44 | 26.44 | -1.56% |
| FYB Formycon AG | VIE | 10 Jul 2026 | 19.46 | 19.46 | 18.26 | 18.84 | -3.19% |
| MARI Marinomed Biotech AG | VIE | 10 Jul 2026 | 9.50 | 9.50 | 8.70 | 9.15 | -3.68% |
| BAVA Bavarian Nordic A/S | VIE | 10 Jul 2026 | 25.68 | 25.68 | 24.38 | 24.56 | -4.36% |
| VLA Valneva SE | VIE | 10 Jul 2026 | 2.33 | 2.35 | 2.20 | 2.20 | -5.74% |
| NVAX Novavax, Inc. | VIE | 10 Jul 2026 | 8.51 | 8.53 | 7.88 | 7.94 | -6.70% |
| ZEAL Zealand Pharma A/S | VIE | 10 Jul 2026 | 40.57 | 40.57 | 37.75 | 37.75 | -6.95% |
| VRTX Vertex Pharmaceuticals Incorporated | VIE | 10 Jul 2026 | 462.10 | 463.00 | 423.60 | 424.75 | -8.08% |